If you look at the chart of consolidated sales in the presentation slides, note that measured over 4 halves, sales growth is rather modest for a so-called growth stock.
The half year announcement is silent on a key metric - the number of tests sold. Why?
On the assumption that the $A stays high, my 2011 intrinsic value on this stock has fallen below $2.00. Sell?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
-0.001(1.43%) |
Mkt cap ! $21.09M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.0¢ | 6.9¢ | $4.173K | 60.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 104046 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 425144 | 4 |
View Market Depth
| Last trade - 12.00pm 13/08/2025 (20 minute delay) ? |
| CST (ASX) Chart |